The legal architecture for federal enforcement against unauthorized e-cigarettes is broader than most coverage of the issue suggests. A March 2026 GAO report (GAO-26-107991) maps out the full range of tools available to the Department of Justice—and which ones actually get used.

The Legal Basis

Two statutes form the primary framework. The Federal Food, Drug, and Cosmetic Act prohibits the distribution of e-cigarette products that are adulterated or misbranded in interstate commerce. Under FDA’s 2016 rule extending its tobacco authority to e-cigarettes, any product sold without FDA premarket authorization is automatically considered adulterated and misbranded—meaning the unauthorized status of a product is itself the legal violation, not any separate showing of harm or deception.

Of the more than 6,000 e-cigarette products estimated to be available for sale in the United States as of June 2024, only 39 had received authorization from the Food and Drug Administration as of December 2025. Every other product on the market is, by definition, illegal—subject to seizure and enforcement action under federal law. The gap between the size of the unauthorized market and the scale of the federal response is the subject of a March 2026 GAO report (GAO-26-107991) examining the Department of Justice’s enforcement record on unauthorized e-cigarettes.